Furthermore, using a sandwich enzyme-linked immunosorbent assay as an additional technique, a significant but non-robust overall reduction in blood plasma SERPINB1 abundance was observed in SCA2 patients already at early stages, though data heterogeneity reinforces the need for larger datasets. Here, SERPINB1 is linked to spinocerebellar ataxia type 2.